Who owns OCUPHIRE PHARMA INC?
- Ticker: IRD
- CUSIP Number: 67577r102
Tip: Access positions for across all investors
Analyze quarterly positions in Ocuphire Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Ocuphire Pharma stock
Who bought or sold OCUPHIRE PHARMA INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| BIOS Capital Management | 995k | $1.2M | 100% | Dec 2024 |
|
| Vanguard Group | 992k | $1.2M | 0% | Dec 2024 |
|
| Geode Capital Management | 314k | $374k | 15% | Dec 2024 |
|
| Voss Capital | 191k | $227k | 100% | Dec 2024 |
|
| Citadel Advisors | 190k | $226k | 87% | Dec 2024 |
|
| Richmond Brothers | 156k | $204k | -19% | Sep 2024 |
|
| Renaissance Technologies | 146k | $173k | 106% | Dec 2024 |
|
| Bridgeway Capital Management | 117k | $139k | -30% | Dec 2024 |
|
| BlackRock | 110k | $131k | 0% | Dec 2024 |
|
| State Street Corporation | 71k | $84k | 0% | Dec 2024 |
|
| Kestra Private Wealth Services | 48k | $58k | 14% | Dec 2024 |
|
| XTX Topco | 44k | $52k | 56% | Dec 2024 |
|
| Empowered Funds | 42k | $50k | 2% | Dec 2024 |
|
| William Blair $ Company | 33k | $40k | 0% | Dec 2024 |
|
| UBS Group | 33k | $39k | 475% | Dec 2024 |
|
| Trust Co Of Toledo Na | 31k | $37k | 0% | Dec 2024 |
|
| Brian McDonald | 30k | $36k | 0% | Dec 2024 |
|
| Diametric Capital | 29k | $35k | -12% | Dec 2024 |
|
| Morgan Stanley | 29k | $34k | -49% | Dec 2024 |
|
| Apollon Wealth Management | 28k | $33k | 100% | Dec 2024 |
|
| Captrust Financial Advisors | 28k | $33k | 56% | Dec 2024 |
|
| Northern Trust | 27k | $32k | 0% | Dec 2024 |
|
| SBI Securities | 25k | $30k | 100% | Dec 2024 |
|
| Jane Street | 18k | $22k | 100% | Dec 2024 |
|
| Financial Gravity Companies | 17k | $20k | 100% | Dec 2024 |
|
| Two Sigma Securities | 16k | $19k | 100% | Dec 2024 |
|
| Bedel Financial Consulting | 15k | $18k | 0% | Dec 2024 |
|
| Raymond James Financial | 15k | $18k | 100% | Dec 2024 |
|
| Advisor Group Holdings | 14k | $18k | 0% | Dec 2024 |
|
| Stokes Family Office | 12k | $14k | 0% | Dec 2024 |
|
| Millennium Management | 12k | $14k | 100% | Dec 2024 |
|
| Raymond James & Associates | 12k | $15k | 100% | Sep 2024 |
|
| Tower Research Capital | 4.1k | $4.9k | 21% | Dec 2024 |
|
| Wells Fargo & Company | 2.8k | $3.3k | 0% | Dec 2024 |
|
| National Bank Of Canada /fi/ | 2.0k | $2.6k | -83% | Sep 2024 |
|
| Eastern Bank | 1.0k | $1.2k | 0% | Dec 2024 |
|
| CarsonAllaria Wealth Management | 1.0k | $1.2k | 0% | Dec 2024 |
|
| MAI Wealth Advisors | 999.00 | $1.2k | 100% | Dec 2024 |
|
| Bank of America Corporation | 242.00 | $288.004200 | 20% | Dec 2024 |
|
| Knoll Capital Management | 45.00 | $53.001000 | -100% | Dec 2024 |
|
| Royal Bank of Canada | 27.00 | $0 | 440% | Dec 2024 |
|
| Northwestern Mutual Wealth Management Company | 10.00 | $12.000000 | 100% | Dec 2024 |
|
| FMR | 1.00 | $1.000000 | 100% | Dec 2024 |
|
Who sold out of Ocuphire Pharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Susquehanna International | Sep 2024 | 50k | $65k |
| Virtu Financial | Sep 2024 | 24k | $31k |
| Springbok Capital Management | Sep 2024 | 12k | $16k |
| Commonwealth Equity Services | Sep 2024 | 12k | $15k |
| Barclays | Sep 2024 | 1.9k | $2.0k |
| Harbour Investments | Sep 2024 | 40.00 | $52.000000 |
| FSA Wealth Management | Sep 2024 | 5.00 | $7.000000 |